Acta Scientific Gastrointestinal Disorders (ASGIS)(ISSN: 2582-1091)

Case Report Volume 5 Issue 7

Neuroendocrine Tumor of Terminal Ileum - Case Report

Ramalho DW1, Mazzini lR1*, Júnior HS2, Camargo JGT2 and Mazzini H3

1Medical Student, Department of Gastroenterology, Pontifícia Universidade Católica de Campinas (PUC-Campinas), Brazil
2Assistant Physician of the Surgery, Urgency and Trauma Service (SCUT) of the Celso Pierro Hospital and Maternity, Puc-Campinas Hospital, Brazil
3Assistant Physician of the General Surgery Service of the Paulínia Municipal Hospital, Brazil

*Corresponding Author: Mazzini lR, Medical Student, Department of Gastroenterology, Pontifícia Universidade Católica de Campinas (PUC-Campinas), Brazil.

Received: June 17, 2022; Published: June 27, 2022

Abstract

Neuroendocrine tumors are malignancis associated or not with hormonal changes, presenting indolently. It has a variable incidence according to the type of study, but usually 0,28-0,8:100.000 [10] is observed, but it may be even rarer depending on its location. The aim of this study is to report a rare case of neuroendocrine tumor of the small intestine diagnosed by unusual methods.

Keywords: Tumor; Neuroendocrine; Indolent

References

  1. Araújo NAA., et al. “Tumores neuroendócrinos: revisão de literatura”. Perspectivas Médicas 1 (2012): 35-41.
  2. Linhares E., et al. “Tumores neuroendócrinos do intestino delgado: experiência do Instituto Nacional de Câncer em 12 anos”. Gastrenterologia Endoscopia Digestiva 1 (2011): 7-12.
  3. Modlin IM., et al. “A five-decade analysis of 13,715 carcinoid tumors”. Cancer 97 (2003): 934-959.
  4. Fernandes LC., et al. “Diagnóstico e tratamento de tumores carcinóides do trato digestivo”. Revista da Associacao Medica Brasileira1 (2002): 87-92.
  5. Pinchot SN., et al. “Carcinoid Tumors”. Oncologist 12 (2008): 1255-1269.
  6. Hemminki K and Li X. “Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden”. Cancer 92 (2001): 2204-2210. 
  7. Maggard M., et al. “Updated population-based review of carcinoid tumors”. Annals of Surgery 240 (2004): 117-122. 
  8. Buitrago MHG., et al. “Tumor neuroendocrino del intestino delgado. Reporte de un caso singular”. Revista Colombiana de Cirugía 4 (2005): e1492. 
  9. Deutsch GB., et al. “Long-term survival with long-acting somatostatin analogues plus aggressive cytoreductive surgery in patients with metastatic neuroendocrine carcinoma”. Journal of the American College of Surgeons 1 (2015): 26-36. 
  10. Araújo NAA., et al. “Tumores neuroendócrinos: revisão de literatura”. Perspectivas Médicas1 (2012): 35-41.
  11. Mirica RE., et al. “Neuroendocrine tumour located in the small intestine, diagnosed by an abdominal ultrasound reassessment of liver haemangiomas”. Journal of Hepato-Gastroenterology 2 (2020): 1-4.
  12. Deguelte S., et al. “Surgery and perioperative management in small intestinal neuroendocrine tumors”. Journal of Clinical Medicine7 (2020): 2319.
  13. Gupta A., et al. “Small bowel neuroendocrine neoplasm: what surgeons want to know”. Abdominal Radiology (2021): 1-11.
  14. Pasquer A., et al. “Principles of Surgical Management of Small Intestinal NET”. Cancers21 (2021): 5473.
  15. Kennedy G., et al. “Routine ileal intubation during screening colonoscopy: a useful maneuver?” Surgical endoscopy12 (2008): 2606-2608.
  16. Cherian S and Singh P. “Is routine ileoscopy useful? An observational study of procedure times, diagnostic yield, and learning curve”. Official Journal of the American College of Gastroenterology| ACG12 (2004): 2324-2329.
  17. Yusoff IF., et al. “Routine colonic mucosal biopsy and ileoscopy increases diagnostic yield in patients undergoing colonoscopy for diarrhea”. Journal of Gastroenterology and Hepatology3 (2002): 276-280.

Citation

Citation: Mazzini lR., et al. “Neuroendocrine Tumor of Terminal Ileum - Case Report". Acta Scientific Gastrointestinal Disorders 5.7 (2022): 85-89.

Copyright

Copyright: © 2022 Mazzini lR., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is November 30, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US